Subscribe to Newsletter

Rob Coker Deputy Editor of The Medicine Maker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

Content by Rob Coker:

Business & Regulation Trends & Forecasts

Celebrating the final day of CPhI Europe

| Rob Coker

The highlights of the trade show and its conference agenda - day 3

Business & Regulation Trends & Forecasts

CPhI Europe continues Today in Milan

| Rob Coker

The highlights of the trade show and its conference agenda - day 2

Business & Regulation Trends & Forecasts

Welcome to CPhI Europe!

| Rob Coker

The highlights of the trade show and its conference agenda - day 1

Discovery & Development Drug Delivery

The Changing Face of Influenza Vaccination

| Rob Coker

Flu changes, ever so slightly, year by year and region by region. The vaccine manufacturing industry must bring changes of its own.

Manufacture Contract Manufacturing Services

Ready for Anything

| Rob Coker

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Discovery & Development Advanced Medicine

Victor Ambros and Gary Ruvkun share 2024 Nobel Prize for Physiology or Medicine

| Rob Coker

The Nobel Prize for Medicine has again been awarded jointly, this time for miRNA discovery and its role in gene regulation

Business & Regulation Business Practice

Driving the Future of Biopharma

| Rob Coker

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

Business & Regulation Standards & Regulation

AstraZeneca Flu Vaccine Approved For Self-Administration

| Rob Coker

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

Discovery & Development Drug Discovery

Cell Wars: A New Hope

| Rob Coker

Researchers use AI to reprogram glioblastoma cancer cells

Manufacture Advanced Medicine

Future Pharma

| Rob Coker | 4 min read

Ever wondered what the distant future of pharma and healthcare looks like? A group of industry experts offer their sage predictions.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register